Twin Tree Management
ICPT

Twin Tree Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Twin Tree Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,800
Closed -$568K – 1544
2015
Q4 		$568K Sell
3,800
-800
-17% -$135K 0.01% 828
2015
Q3 		$763K Sell
4,600
-6,100
-57% -$1.34M 0.02% 629
2015
Q2 		$2.58M Buy
+10,700
New +$2.85M 0.06% 328

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Twin Tree Management's ICPT Position: Q2 2019 in Review

Twin Tree Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2019, closing a stake of 542 shares — an estimated $61K sold.

Twin Tree Management first reported a position in ICPT in Q2 2015 and held it in 5 quarters. The position peaked at $703K in Q2 2015. 196 funds tracked by Wall St. Rank hold ICPT as of Q2 2019.

  • Twin Tree Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Twin Tree Management sold 542 Intercept Pharmaceuticals, Inc. shares in Q2 2019, an estimated $61K.
  • Twin Tree Management first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2015 and held it in 5 quarters.
  • Twin Tree Management's Intercept Pharmaceuticals, Inc. position peaked at $703K in Q2 2015.
  • 196 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2019.

Based on Twin Tree Management's 13F filing for Q2 2019, filed 12 Aug 2019.